Results
The age and body mass index (BMI)
of 150 patients in this study ranged from 16 to 80 y (49.83 ± 14.53) and
12.41 to 41.79 kg/m2 (25.09 ± 5.32), respectively.
Tables 1 and 2 show the participants’ demographic, clinical, and medical
characteristics.
Table 1 near here.
Among the participants, 17.3% (n=26) had hematologic cancers. Cancer
incidence ranged from 1 to 180 months (23.26 ± 29.3). The frequency of
chemotherapy and radiotherapy sessions varied from 1 to 13 (3.61 ±
2.37), 0 to 70 (8.24 ± 9.79), and 0 to 50 (5.50 ± 11.5) times,
respectively, for patients admitted to the hospital due to cancer.
Table 2 near here.
Total MEQ scores ranged between 41 and 74 (56.6 ± 6.34). In this study,
2% (n=3) of patients were definitely morning types, 38% (n=57) were
moderately morning types, 59.3% (n=89) were neither types, 0.7% (n=1)
was moderately evening types, and no patients were definitely evening
types. Normal distribution was observed for MEQ scores among the
participants (Figure 1).
Figure 1 near here.
According to Table 3 and 4, the mean ages of completely and moderately
morning types were greater than those of all other types. The
distribution of circadian rhythms was nearly identical between male and
female participants. Employed and unemployed individuals, as well as
patients with varying levels of education, were frequently morning and
neither types. The ANOVA test did not reveal significant associations
between chronotype and age, time of cancer onset, cancer-specific
hospitalization, chemotherapy, or radiotherapy sessions. Furthermore,
Fisher’s exact test revealed no correlation between employment status,
marital status, gender, treatment methods, level of education, patient
condition, and types of circadian rhythm.
Table 3 and 4 near here.